-
1
-
-
0037389670
-
Epidemiology of chronic renal failure in children: Data from the ItalKid project
-
Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F (2003) Epidemiology of chronic renal failure in children: Data from the ItalKid project. Pediatrics 111:e382-e387
-
(2003)
Pediatrics
, vol.111
-
-
Ardissino, G.1
Dacco, V.2
Testa, S.3
Bonaudo, R.4
Claris-Appiani, A.5
Taioli, E.6
Marra, G.7
Edefonti, A.8
Sereni, F.9
-
2
-
-
0037374175
-
Recent advances in management of type 2 diabetes and nephropathy: Lessons from the RENAAL study
-
Keane WF, Lyle PA (2003) Recent advances in management of type 2 diabetes and nephropathy: Lessons from the RENAAL study. Am J Kidney Dis 41:S22-S25
-
(2003)
Am J Kidney Dis
, vol.41
-
-
Keane, W.F.1
Lyle, P.A.2
-
3
-
-
0031819895
-
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN)
-
Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G (1998) Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int 53:1209-1216
-
(1998)
Kidney Int
, vol.53
, pp. 1209-1216
-
-
Ruggenenti, P.1
Perna, A.2
Mosconi, L.3
Pisoni, R.4
Remuzzi, G.5
-
4
-
-
36749080967
-
Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: Role of antihypertensive drug management
-
Simonetti GD, Santoro L, Ferrarini A, Crosazzo-Franscini L, Fossali E, Bianchetti MG (2007) Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: Role of antihypertensive drug management. Paediatr Drugs 9:413-418
-
(2007)
Paediatr Drugs
, vol.9
, pp. 413-418
-
-
Simonetti, G.D.1
Santoro, L.2
Ferrarini, A.3
Crosazzo-Franscini, L.4
Fossali, E.5
Bianchetti, M.G.6
-
5
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
de Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
Remuzzi, G.7
Snapinn, S.M.8
Zhang, Z.9
Shahinfar, S.10
-
6
-
-
0027517659
-
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group
-
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462
-
(1993)
N Engl J Med
, vol.329
, pp. 1456-1462
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Bain, R.P.3
Rohde, R.D.4
-
7
-
-
0038188560
-
Retarding progression of chronic renal disease: The neglected issue of residual proteinuria
-
Ruggenenti P, Perna A, Remuzzi G (2003) Retarding progression of chronic renal disease: The neglected issue of residual proteinuria. Kidney Int 63:2254-2261
-
(2003)
Kidney Int
, vol.63
, pp. 2254-2261
-
-
Ruggenenti, P.1
Perna, A.2
Remuzzi, G.3
-
8
-
-
0030931894
-
Role of the renin-angiotensin-aldosterone system in the progression of renal disease: A critical review
-
Ibrahim HN, Rosenberg ME, Hostetter TH (1997) Role of the renin-angiotensin-aldosterone system in the progression of renal disease: A critical review. Semin Nephrol 17:431-440
-
(1997)
Semin Nephrol
, vol.17
, pp. 431-440
-
-
Ibrahim, H.N.1
Rosenberg, M.E.2
Hostetter, T.H.3
-
9
-
-
0019891089
-
Rise of plasma aldosterone during long-term captopril treatment
-
Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A (1981) Rise of plasma aldosterone during long-term captopril treatment. N Engl J Med 304:1110
-
(1981)
N Engl J Med
, vol.304
, pp. 1110
-
-
Staessen, J.1
Lijnen, P.2
Fagard, R.3
Verschueren, L.J.4
Amery, A.5
-
10
-
-
0035124068
-
Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease
-
Shiigai T, Shichiri M (2001) Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease. Am J Kidney Dis 37:477-483
-
(2001)
Am J Kidney Dis
, vol.37
, pp. 477-483
-
-
Shiigai, T.1
Shichiri, M.2
-
11
-
-
50449127080
-
Secretion of a salt-retaining hormone by the mammalian adrenal cortex
-
Simpson SA, Tait JF, Bush IE (1952) Secretion of a salt-retaining hormone by the mammalian adrenal cortex. Lancet 2:226-228
-
(1952)
Lancet
, vol.2
, pp. 226-228
-
-
Simpson, S.A.1
Tait, J.F.2
Bush, I.E.3
-
13
-
-
33845867691
-
Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade
-
Del Vecchio L, Procaccio M, Vigano S, Cusi D (2007) Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade. Nat Clin Pract Nephrol 3:42-49
-
(2007)
Nat Clin Pract Nephrol
, vol.3
, pp. 42-49
-
-
Del Vecchio, L.1
Procaccio, M.2
Vigano, S.3
Cusi, D.4
-
15
-
-
0032570807
-
Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation
-
Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C (1998) Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 273:4883-4891
-
(1998)
J Biol Chem
, vol.273
, pp. 4883-4891
-
-
Silvestre, J.S.1
Robert, V.2
Heymes, C.3
Aupetit-Faisant, B.4
Mouas, C.5
Moalic, J.M.6
Swynghedauw, B.7
Delcayre, C.8
-
16
-
-
0029788193
-
Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin
-
Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H, Takeda R (1996) Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab 81:2797-2800
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 2797-2800
-
-
Takeda, Y.1
Miyamori, I.2
Yoneda, T.3
Hatakeyama, H.4
Inaba, S.5
Furukawa, K.6
Mabuchi, H.7
Takeda, R.8
-
17
-
-
49649085000
-
The aggravating mechanisms of aldosterone on kidney fibrosis
-
Remuzzi G, Cattaneo D, Perico N (2008) The aggravating mechanisms of aldosterone on kidney fibrosis. J Am Soc Nephrol 19:1459-1462
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1459-1462
-
-
Remuzzi, G.1
Cattaneo, D.2
Perico, N.3
-
18
-
-
31544477239
-
Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts
-
Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A (2005) Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46:1039-1045
-
(2005)
Hypertension
, vol.46
, pp. 1039-1045
-
-
Nagai, Y.1
Miyata, K.2
Sun, G.P.3
Rahman, M.4
Kimura, S.5
Miyatake, A.6
Kiyomoto, H.7
Kohno, M.8
Abe, Y.9
Yoshizumi, M.10
Nishiyama, A.11
-
19
-
-
0029022285
-
Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart
-
Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP (1995) Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation 92:175-182
-
(1995)
Circulation
, vol.92
, pp. 175-182
-
-
Lombes, M.1
Alfaidy, N.2
Eugene, E.3
Lessana, A.4
Farman, N.5
Bonvalet, J.P.6
-
20
-
-
1642281192
-
Brain mineralocorticoid receptors: Orchestrators of hypertension and end-organ disease
-
Gomez-Sanchez EP (2004) Brain mineralocorticoid receptors: Orchestrators of hypertension and end-organ disease. Curr Opin Nephrol Hypertens 13:191-196
-
(2004)
Curr Opin Nephrol Hypertens
, vol.13
, pp. 191-196
-
-
Gomez-Sanchez, E.P.1
-
21
-
-
0027174723
-
Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron
-
Todd-Turla KM, Schnermann J, Fejes-Toth G, Naray-Fejes-Toth A, Smart A, Killen PD, Briggs JP (1993) Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol Renal Physiol 264:F781-F791
-
(1993)
Am J Physiol Renal Physiol
, vol.264
-
-
Todd-Turla, K.M.1
Schnermann, J.2
Fejes-Toth, G.3
Naray-Fejes-Toth, A.4
Smart, A.5
Killen, P.D.6
Briggs, J.P.7
-
22
-
-
0033849916
-
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
-
Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB (2000) Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int 58:1219-1227
-
(2000)
Kidney Int
, vol.58
, pp. 1219-1227
-
-
Brown, N.J.1
Nakamura, S.2
Ma, L.3
Nakamura, I.4
Donnert, E.5
Freeman, M.6
Vaughan, D.E.7
Fogo, A.B.8
-
23
-
-
12144286297
-
Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats
-
Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y (2004) Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43:841-848
-
(2004)
Hypertension
, vol.43
, pp. 841-848
-
-
Nishiyama, A.1
Yao, L.2
Nagai, Y.3
Miyata, K.4
Yoshizumi, M.5
Kagami, S.6
Kondo, S.7
Kiyomoto, H.8
Shokoji, T.9
Kimura, S.10
Kohno, M.11
Abe, Y.12
-
24
-
-
85047676796
-
Aldosterone and cardiac fibrosis: In vitro studies
-
Fullerton MJ, Funder JW (1994) Aldosterone and cardiac fibrosis: In vitro studies. Cardiovasc Res 28:1863-1867
-
(1994)
Cardiovasc Res
, vol.28
, pp. 1863-1867
-
-
Fullerton, M.J.1
Funder, J.W.2
-
25
-
-
64949189157
-
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt
-
doi: 10.1038/ki.2009.9
-
Lea WB, Kwak ES, Luther JM, Fowler SM, Wang Z, Ma J, Fogo AB, Brown NJ (2009) Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int. doi: 10.1038/ki.2009.9
-
(2009)
Kidney Int
-
-
Lea, W.B.1
Kwak, E.S.2
Luther, J.M.3
Fowler, S.M.4
Wang, Z.5
Ma, J.6
Fogo, A.B.7
Brown, N.J.8
-
26
-
-
56549094967
-
Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone
-
Chiga M, Rai T, Yang SS, Ohta A, Takizawa T, Sasaki S, Uchida S (2008) Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Kidney Int 74:1403-1409
-
(2008)
Kidney Int
, vol.74
, pp. 1403-1409
-
-
Chiga, M.1
Rai, T.2
Yang, S.S.3
Ohta, A.4
Takizawa, T.5
Sasaki, S.6
Uchida, S.7
-
27
-
-
25644434249
-
Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor
-
Xue C, Siragy HM (2005) Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 46:584-590
-
(2005)
Hypertension
, vol.46
, pp. 584-590
-
-
Xue, C.1
Siragy, H.M.2
-
28
-
-
0034068040
-
Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model
-
Ibrahim HN, Hostetter TH (2000) Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model. J Am Soc Nephrol 11:625-631
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 625-631
-
-
Ibrahim, H.N.1
Hostetter, T.H.2
-
30
-
-
0025952454
-
Glomerular hypertrophy accelerates hypertensive glomerular injury in rats
-
Miller PL, Rennke HG, Meyer TW (1991) Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol Renal Physiol 261:F459-F465
-
(1991)
Am J Physiol Renal Physiol
, vol.261
-
-
Miller, P.L.1
Rennke, H.G.2
Meyer, T.W.3
-
31
-
-
0034119204
-
Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats
-
Sun Y, Zhang J, Zhang JQ, Ramires FJ (2000) Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension 35:1078-1084
-
(2000)
Hypertension
, vol.35
, pp. 1078-1084
-
-
Sun, Y.1
Zhang, J.2
Zhang, J.Q.3
Ramires, F.J.4
-
32
-
-
41849123818
-
Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease
-
Toto R, Palmer BF (2008) Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease. Am J Nephrol 28:372-380
-
(2008)
Am J Nephrol
, vol.28
, pp. 372-380
-
-
Toto, R.1
Palmer, B.F.2
-
33
-
-
0029940121
-
Chymase-dependent angiotensin II forming systems in humans
-
Urata H, Nishimura H, Ganten D (1996) Chymase-dependent angiotensin II forming systems in humans. Am J Hypertens 9:277-284
-
(1996)
Am J Hypertens
, vol.9
, pp. 277-284
-
-
Urata, H.1
Nishimura, H.2
Ganten, D.3
-
34
-
-
0141617520
-
Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
-
Sato A, Saruta T (2003) Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy. Am J Hypertens 16:781-788
-
(2003)
Am J Hypertens
, vol.16
, pp. 781-788
-
-
Sato, A.1
Saruta, T.2
-
35
-
-
33845238078
-
Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors
-
Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T (2006) Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors. J Am Soc Nephrol 17:3438-3446
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 3438-3446
-
-
Nagase, M.1
Yoshida, S.2
Shibata, S.3
Nagase, T.4
Gotoda, T.5
Ando, K.6
Fujita, T.7
-
36
-
-
34548163060
-
The incidence and implications of aldosterone breakthrough
-
Bomback AS, Klemmer PJ (2007) The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 3:486-492
-
(2007)
Nat Clin Pract Nephrol
, vol.3
, pp. 486-492
-
-
Bomback, A.S.1
Klemmer, P.J.2
-
37
-
-
0026500611
-
Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level
-
Quan ZY, Walser M, Hill GS (1992) Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level. Kidney Int 41:326-333
-
(1992)
Kidney Int
, vol.41
, pp. 326-333
-
-
Quan, Z.Y.1
Walser, M.2
Hill, G.S.3
-
38
-
-
0029810416
-
Role of aldosterone in the remnant kidney model in the rat
-
Greene EL, Kren S, Hostetter TH (1996) Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98:1063-1068
-
(1996)
J Clin Invest
, vol.98
, pp. 1063-1068
-
-
Greene, E.L.1
Kren, S.2
Hostetter, T.H.3
-
39
-
-
0031600240
-
Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats
-
Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr (1998) Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 31:451-458
-
(1998)
Hypertension
, vol.31
, pp. 451-458
-
-
Rocha, R.1
Chander, P.N.2
Khanna, K.3
Zuckerman, A.4
Stier Jr., C.T.5
-
40
-
-
0032921738
-
Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats
-
Rocha R, Chander PN, Zuckerman A, Stier CT Jr (1999) Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 33:232-237
-
(1999)
Hypertension
, vol.33
, pp. 232-237
-
-
Rocha, R.1
Chander, P.N.2
Zuckerman, A.3
Stier Jr., C.T.4
-
41
-
-
0036314951
-
Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats
-
Naruse M, Tanabe A, Sato A, Takagi S, Tsuchiya K, Imaki T, Takano K (2002) Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats. Hypertension 40:28-33
-
(2002)
Hypertension
, vol.40
, pp. 28-33
-
-
Naruse, M.1
Tanabe, A.2
Sato, A.3
Takagi, S.4
Tsuchiya, K.5
Imaki, T.6
Takano, K.7
-
42
-
-
47549114629
-
Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats
-
Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T (2008) Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Eur J Pharmacol 589:264-271
-
(2008)
Eur J Pharmacol
, vol.589
, pp. 264-271
-
-
Taira, M.1
Toba, H.2
Murakami, M.3
Iga, I.4
Serizawa, R.5
Murata, S.6
Kobara, M.7
Nakata, T.8
-
43
-
-
0033028679
-
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
-
MacFadyen RJ, Lee AF, Morton JJ, Pringle SD, Struthers AD (1999) How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart 82:57-61
-
(1999)
Heart
, vol.82
, pp. 57-61
-
-
MacFadyen, R.J.1
Lee, A.F.2
Morton, J.J.3
Pringle, S.D.4
Struthers, A.D.5
-
44
-
-
0037222490
-
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
-
Sato A, Hayashi K, Naruse M, Saruta T (2003) Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 41:64-68
-
(2003)
Hypertension
, vol.41
, pp. 64-68
-
-
Sato, A.1
Hayashi, K.2
Naruse, M.3
Saruta, T.4
-
45
-
-
0019946282
-
Increase in plasma aldosterone during prolonged captopril treatment
-
Lijnen P, Staessen J, Fagard R, Amery A (1982) Increase in plasma aldosterone during prolonged captopril treatment. Am J Cardiol 49:1561-1563
-
(1982)
Am J Cardiol
, vol.49
, pp. 1561-1563
-
-
Lijnen, P.1
Staessen, J.2
Fagard, R.3
Amery, A.4
-
46
-
-
12144252958
-
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
-
Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH (2004) Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 47:1936-1939
-
(2004)
Diabetologia
, vol.47
, pp. 1936-1939
-
-
Schjoedt, K.J.1
Andersen, S.2
Rossing, P.3
Tarnow, L.4
Parving, H.H.5
-
47
-
-
0035922443
-
Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease
-
Chrysostomou A, Becker G (2001) Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. N Engl J Med 345:925-926
-
(2001)
N Engl J Med
, vol.345
, pp. 925-926
-
-
Chrysostomou, A.1
Becker, G.2
-
48
-
-
33746558934
-
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
-
Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ (2006) Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin J Am Soc Nephrol 1:256-262
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, pp. 256-262
-
-
Chrysostomou, A.1
Pedagogos, E.2
MacGregor, L.3
Becker, G.J.4
-
49
-
-
40149090641
-
Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: Addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker
-
Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T (2008) Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: Addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Hypertens Res 31:59-67
-
(2008)
Hypertens Res
, vol.31
, pp. 59-67
-
-
Furumatsu, Y.1
Nagasawa, Y.2
Tomida, K.3
Mikami, S.4
Kaneko, T.5
Okada, N.6
Tsubakihara, Y.7
Imai, E.8
Shoji, T.9
-
50
-
-
49749125234
-
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: An open-label crossover randomized controlled trial
-
Tylicki L, Rutkowski P, Renke M, Larczynski W, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B (2008) Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: An open-label crossover randomized controlled trial. Am J Kidney Dis 52:486-493
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 486-493
-
-
Tylicki, L.1
Rutkowski, P.2
Renke, M.3
Larczynski, W.4
Aleksandrowicz, E.5
Lysiak-Szydlowska, W.6
Rutkowski, B.7
-
51
-
-
33750274950
-
Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function
-
van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F (2006) Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function. J Hypertens 24:2285-2292
-
(2006)
J Hypertens
, vol.24
, pp. 2285-2292
-
-
van den Meiracker, A.H.1
Baggen, R.G.2
Pauli, S.3
Lindemans, A.4
Vulto, A.G.5
Poldermans, D.6
Boomsma, F.7
-
52
-
-
33745282934
-
Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample
-
Fox CS, Larson MG, Hwang SJ, Leip EP, Rifai N, Levy D, Benjamin EJ, Murabito JM, Meigs JB, Vasan RS (2006) Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int 69:2064-2069
-
(2006)
Kidney Int
, vol.69
, pp. 2064-2069
-
-
Fox, C.S.1
Larson, M.G.2
Hwang, S.J.3
Leip, E.P.4
Rifai, N.5
Levy, D.6
Benjamin, E.J.7
Murabito, J.M.8
Meigs, J.B.9
Vasan, R.S.10
-
53
-
-
38549083146
-
Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension
-
Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Aban I, Oparil S, Calhoun DA (2008) Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension. Hypertension 51:339-344
-
(2008)
Hypertension
, vol.51
, pp. 339-344
-
-
Pimenta, E.1
Gaddam, K.K.2
Pratt-Ubunama, M.N.3
Nishizaka, M.K.4
Aban, I.5
Oparil, S.6
Calhoun, D.A.7
-
54
-
-
0041318968
-
Nongenomic vascular action of aldosterone in the glomerular microcirculation
-
Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F, Takeuchi K, Ito S (2003) Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 14:2255-2263
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2255-2263
-
-
Arima, S.1
Kohagura, K.2
Xu, H.L.3
Sugawara, A.4
Abe, T.5
Satoh, F.6
Takeuchi, K.7
Ito, S.8
-
55
-
-
33845302661
-
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
-
Bianchi S, Bigazzi R, Campese VM (2006) Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int 70:2116-2123
-
(2006)
Kidney Int
, vol.70
, pp. 2116-2123
-
-
Bianchi, S.1
Bigazzi, R.2
Campese, V.M.3
-
56
-
-
20544465842
-
Antagonists of aldosterone and proteinuria in patients with CKD: An uncontrolled pilot study
-
Bianchi S, Bigazzi R, Campese VM (2005) Antagonists of aldosterone and proteinuria in patients with CKD: An uncontrolled pilot study. Am J Kidney Dis 46:45-51
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 45-51
-
-
Bianchi, S.1
Bigazzi, R.2
Campese, V.M.3
-
57
-
-
13244298395
-
Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease
-
Sato A, Hayashi K, Saruta T (2005) Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease. Am J Hypertens 18:44-49
-
(2005)
Am J Hypertens
, vol.18
, pp. 44-49
-
-
Sato, A.1
Hayashi, K.2
Saruta, T.3
-
58
-
-
4644313400
-
Effect of spironolactone on K(+) homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients
-
Michea L, Vukusich A, Gonzalez M, Zehnder C, Marusic ET (2004) Effect of spironolactone on K(+) homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients. Kidney Int 66:1647-1653
-
(2004)
Kidney Int
, vol.66
, pp. 1647-1653
-
-
Michea, L.1
Vukusich, A.2
Gonzalez, M.3
Zehnder, C.4
Marusic, E.T.5
-
59
-
-
0242320293
-
Safety of low-dose spironolactone administration in chronic haemodialysis patients
-
Saudan P, Mach F, Perneger T, Schnetzler B, Stoermann C, Fumeaux Z, Rossier M, Martin PY (2003) Safety of low-dose spironolactone administration in chronic haemodialysis patients. Nephrol Dial Transplant 18:2359-2363
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 2359-2363
-
-
Saudan, P.1
Mach, F.2
Perneger, T.3
Schnetzler, B.4
Stoermann, C.5
Fumeaux, Z.6
Rossier, M.7
Martin, P.Y.8
-
60
-
-
20544445158
-
Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients
-
Gross E, Rothstein M, Dombek S, Juknis HI (2005) Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients. Am J Kidney Dis 46:94-101
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 94-101
-
-
Gross, E.1
Rothstein, M.2
Dombek, S.3
Juknis, H.I.4
-
61
-
-
3242805216
-
Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure
-
Wuhl E, Mehls O, Schaefer F (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768-776
-
(2004)
Kidney Int
, vol.66
, pp. 768-776
-
-
Wuhl, E.1
Mehls, O.2
Schaefer, F.3
-
62
-
-
34548167909
-
No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy - Report from the ItalKid Project database
-
Ardissino G, Vigano S, Testa S, Dacco V, Paglialonga F, Leoni A, Belingheri M, Avolio L, Ciofani A, Claris-Appiani A, Cusi D, Edefonti A, Ammenti A, Cecconi M, Fede C, Ghio L, La Manna A, Maringhini S, Papalia T, Pela I, Pisanello L, Ratsch IM (2007) No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy - report from the ItalKid Project database. Nephrol Dial Transplant 22:2525-2530
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 2525-2530
-
-
Ardissino, G.1
Vigano, S.2
Testa, S.3
Dacco, V.4
Paglialonga, F.5
Leoni, A.6
Belingheri, M.7
Avolio, L.8
Ciofani, A.9
Claris-Appiani, A.10
Cusi, D.11
Edefonti, A.12
Ammenti, A.13
Cecconi, M.14
Fede, C.15
Ghio, L.16
La Manna, A.17
Maringhini, S.18
Papalia, T.19
Pela, I.20
Pisanello, L.21
Ratsch, I.M.22
more..
-
63
-
-
33750993170
-
The effect of aldosterone blockade in patients with Alport syndrome
-
Kaito H, Nozu K, Iijima K, Nakanishi K, Yoshiya K, Kanda K, Przybyslaw Krol R, Yoshikawa N, Matsuo M (2006) The effect of aldosterone blockade in patients with Alport syndrome. Pediatr Nephrol 21:1824-1829
-
(2006)
Pediatr Nephrol
, vol.21
, pp. 1824-1829
-
-
Kaito, H.1
Nozu, K.2
Iijima, K.3
Nakanishi, K.4
Yoshiya, K.5
Kanda, K.6
Przybyslaw Krol, R.7
Yoshikawa, N.8
Matsuo, M.9
-
64
-
-
17644388479
-
Clinical experience with spironolactone in pediatrics
-
Buck ML (2005) Clinical experience with spironolactone in pediatrics. Ann Pharmacother 39:823-828
-
(2005)
Ann Pharmacother
, vol.39
, pp. 823-828
-
-
Buck, M.L.1
|